A0A829CBJ4 (A0A829CBJ4_9MYCO) Mycobacterium orygis 112400015
Enoyl-[acyl-carrier-protein] reductase [NADH] UniProtKBInterProInteractive Modelling
269 aa; Sequence (Fasta) ;
10 identical sequences: Mycobacterium tuberculosis: P9WGR1, P9WGR0, A0A0H3LFJ7, A5U2I8; Mycobacterium bovis: A0A0H3M400; Mycobacterium sp. XDR-14: A0AAW8I658; Mycobacterium bovis: P0A5Y7, A0A679LDV0; Mycobacterium tuberculosis: M9TGV3; Mycobacterium orygis: A0AAU0QBI2
It is possible new templates exist for this target since these models were created.
Available Structures
117 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of InhA:01 TCR in complex with HLA-E (Y84C) bound to InhA (53-61 GCG) |
Heteromer P13747; P61769; P9WGR1; | 75.0 | 8×EDO; | |||
| HLA-E*01:03 in complex with Mtb44 |
Heteromer P13747; P61769; P9WGR1; | 100 | 4×SO4; | |||
| HLA-E*01:03 in complex with the Mtb44 peptide variant: Mtb44*P2-Gln. |
Heteromer P13747; P61769; P9WGR1; | 88.89 | 2×SO4; | |||
| Crystal structure of InhA:01 TCR in complex with HLA-E bound to InhA (53-61) |
Heteromer P13747; P61769; P9WGR1; | 100 | ||||
| Crystal structure of high affinity TCR in complex with pHLA harbouring bacterial peptide |
Heteromer P13747; P61769; P9WGR1; | 100 | ||||
| HLA-E*01:03 in complex with the Mtb44 peptide variant: Mtb44*P9-Phe. |
Heteromer P13747; P61769; P9WGR1; | 88.89 | 1×SO4; | |||
| Crystal structure of InhA:01 TCR in complex with HLA-E (S147C) bound to InhA (53-61 H3C) |
Heteromer P13747; P61769; P9WGR1; | 88.89 | ||||
| HLA-E*01:03 in complex with the Mtb44 peptide variant: Mtb44*P2-Phe. |
Heteromer P13747; P61769; P9WGR1; | 88.89 | 3×ZN; 3×SO4; | |||
| Crystal structure of InhA:01 TCR in complex with HLA-E (F116C) bound to InhA (53-61 H4C) |
Heteromer P13747; P61769; P9WGR1; | 100 | 4×EDO; | |||
| structure of InhA from mycobacterium tuberculosis in complex with inhibitor 7-((1-(3-Hydroxy-4-phen… | homo-4-mer | 100 | 4×NAD; 4×VZR; | |||
| Structure of the enoyl-ACP reductase of Mycobacterium tuberculosis InhA, inhibited with the active … | homo-4-mer | 100 | 4×NAD; 4×ZID; 8×EPE; 16×DMS; 8×NA; | |||
| InhA in complex with a DNA encoded library hit | homo-4-mer | 100.0 | 4×NAD; 4×S72; | |||
| Crystal structure of Mycobacterium tuberculosis InhA in complex with inhibitor PT92 | homo-4-mer | 100 | 4×NAD; 4×2TK; | |||
| structure of InhA from mycobacterium tuberculosis in complex with N-((1-(3-hydroxy-4-phenoxybenzyl)… | homo-4-mer | 100 | 4×NAD; 4×VZI; 3×EDO; 5×NA; 1×ACT; | |||
| Crystal structure of Mycobacterium tuberculosis enoyl reductase (INHA) complexed with 1-CYCLOHEXYL-… | homo-4-mer | 100 | 4×NAD; 4×566; | |||
| Crystal structure of Mycobacterium tuberculosis enoyl reductase (INHA) complexed WITH 1-CYCLOHEXYL-… | homo-4-mer | 100 | 4×NAD; 4×641; | |||
| Mtb InhA complex with Pyradizinone compound 14 | homo-4-mer | 100.0 | 4×NAD; 4×9G4; 2×MG; | |||
| Crystal structure of Mycobacterium tuberculosis enoyl reductase (INHA) complexed with N-(3-bromophe… | homo-4-mer | 100 | 4×NAD; 4×665; | |||
| Discovery of pyrimidine isoxazoles InhA in complex with compound 23 | homo-4-mer | 100.0 | 4×NAD; 4×KXU; | |||
| InhA in complex with a DNA encoded library hit | homo-4-mer | 100 | 4×NAD; 2×9CV; | |||
| InhA in complex with a DNA encoded library hit | homo-4-mer | 100.0 | 4×NAD; 2×EEH; | |||
| Crystal structure of M. tuberculosis InhA in complex with NAD+ and 3-hydroxynaphthalene-2-carboxyli… | homo-4-mer | 100 | 4×NAD; 4×BZJ; 4×EPE; | |||
| InhA in complex with a DNA encoded library hit | homo-4-mer | 100.0 | 4×NAD; 1×MG; 1×JDD; | |||
| InhA in complex with a DNA encoded library hit | homo-4-mer | 100 | 4×NAD; 3×MG; 2×9NU; | |||
| InhA Y158F mutant in complex with NADH from Mycobacterium tuberculosis | homo-4-mer | 99.63 | 16×NA; 4×NAD; 24×GOL; 4×MPD; | |||
| crystal structure of M. tuberculosis InhA inhibited by PT70 | homo-4-mer | 100 | 4×NAD; 4×TCU; 1×DMS; | |||
| Discovery of pyrimidine isoxazoles InhA in complex with compound 6 | homo-4-mer | 100 | 4×NAD; 4×MG; 4×HRW; | |||
| Crystal structure of Mycobacterium tuberculosis InhA in complex with inhibitor PT119 in 2.4 M aceta… | homo-4-mer | 100 | 4×NAD; 4×JUS; 44×ACT; | |||
| CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ENOYL REDUCTASE (INHA) COMPLEXED WITH N-(3-CHLORO-2… | homo-4-mer | 100 | 4×NAD; 4×468; | |||
| Mtb InhA complex with Methyl-thiazole compound 7 | homo-4-mer | 100 | 4×NAD; 2×NA; 4×VMY; | |||
| Discovery of pyrimidine isoxazoles InhA in complex with compound 10 | homo-4-mer | 100.0 | 4×NAD; 4×UUD; 2×ACT; | |||
| Discovery of pyrimidine isoxazoles InhA in complex with compound 15 | homo-4-mer | 100 | 4×NAD; 4×MG; 4×1PE; 4×A0C; | |||
| Crystal structure of M. tuberculosis InhA inhibited by PT506 | homo-4-mer | 100 | 4×NAD; 4×XTV; | |||
| STRUCTURE OF INHA FROM MYCOBACTERIUM TUBERCULOSIS COMPLEXED TO NADH | homo-4-mer | 100 | 4×NAD; 4×MPD; 8×DMS; | |||
| How nature bridges the gap: Crystallographic elucidation of pyridomycin binding to InhA | homo-4-mer | 100.0 | 3×NAD; 3×PYW; | |||
| Crystal structure of InhA bound to triclosan derivative | homo-4-mer | 100 | 4×NAD; 4×JPL; | |||
| Crystal structure of InhA bound to triclosan derivative 17 | homo-4-mer | 100 | 4×NAD; 4×8PC; | |||
| Discovery of pyrimidine isoxazoles InhA in complex with compound 9 | homo-4-mer | 100 | 4×NAD; 4×MG; 4×KI5; | |||
| The effect of isoleucine to alanine mutation on InhA enzyme crystallization pattern and inhibition … | homo-4-mer | 99.63 | 4×NAD; | |||
| Crystal structure of wild type Enoyl-ACP(CoA) reductase from Mycobacterium tuberculosis in complex … | homo-4-mer | 100 | 4×ZID; | |||
| Crystal structure of M. tuberculosis InhA inhibited by PT512 | homo-4-mer | 100 | 4×NAD; 4×XT0; | |||
| Crystal structure of M. tuberculosis InhA inhibited by PT514 | homo-4-mer | 100 | 4×NAD; 4×53K; 1×CL; | |||
| Crystal structure of Isoniazid-resistant I21V Enoyl-ACP(CoA) reductase mutant enzyme from Mycobacte… | homo-4-mer | 99.63 | 4×NAI; | |||
| Crystal structure of M. tuberculosis InhA inhibited by SKTS1 | homo-4-mer | 100 | 4×NAD; 4×F9T; 20×CL; 4×NA; | |||
| Mtb InhA complex with Methyl-thiazole compound 11 | homo-4-mer | 100 | 4×NAD; 4×IBH; | |||
| crystal structure of M. tuberculosis InhA inhibited by PT70 | homo-4-mer | 100 | 4×NAD; 4×TCU; 4×DMS; | |||
| CRYSTAL STRUCTURE of ISONIAZID-RESISTANT S94A ENOYL-ACP(COA) REDUCTASE MUTANT ENZYME FROM MYCOBACTE… | homo-4-mer | 99.63 | ||||
| Crystal structure of the InhA:GSK_SB713 complex | homo-4-mer | 100 | 4×NAD; 2×713; | |||
| Crystal Structure of Isoniazid-resistant S94A ENOYL-ACP(COA) Reductase Mutant Enzyme from MYCOBACTE… | homo-4-mer | 99.63 | 4×ZID; | |||
| Crystal structure of Isoniazid-resistant I47T Enoyl-ACP(CoA) reductase mutant enzyme from Mycobacte… | homo-4-mer | 99.63 | 4×NAI; | |||
| Crystal Structure of Isoniazid-resistant I21V Enoyl-ACP(COA) Reductase Mutant Enzyme From MYCOBACTE… | homo-4-mer | 99.63 | 4×ZID; | |||
| Mycobacterium tuberculosis InhA bound with ETH-NAD adduct | homo-4-mer | 99.63 | 4×EAD; | |||
| Substrate-like binding mode of inhibitor PT155 to the Mycobacterium tuberculosis enoyl-ACP reductas… | homo-4-mer | 100.0 | 4×NAD; 4×1S5; 4×CL; 16×2NV; 2×EPE; | |||
| Competition of the small inhibitor PT91 with large fatty acyl substrate of the Mycobacterium tuberc… | homo-4-mer | 100 | 4×NAD; 4×1US; | |||
| Crystal structure of Isoniazid-resistant S94A Enoyl-ACP(CoA) reductase mutant enzyme from Mycobacte… | homo-4-mer | 99.63 | 4×NAI; | |||
| Crystal structure of Mycobacterium tuberculosis enoyl reductase (InhA) inhibited by triclosan | homo-4-mer | 100.0 | 4×TCL; 4×NAD; | |||
| The effect of valine to alanine mutation on InhA enzyme crystallization pattern and substrate bindi… | homo-4-mer | 99.62 | 4×NAD; 4×TCU; 1×NA; | |||
| Crystal structure of InhA bound to triclosan derivative | homo-4-mer | 100 | 4×NAD; 4×JPM; | |||
| Substrate-binding loop movement with inhibitor PT10 in the tetrameric Mycobacterium tuberculosis en… | homo-4-mer | 100 | 4×NAD; 4×1TN; | |||
| Encoded library technology as a source of hits for the discovery and lead optimization of a potent … | homo-4-mer | 100 | 4×KV1; 4×NAD; | |||
| InhA (T2A mutant) complexed with 5-((5-Amino-3-methyl-1H-pyrazol-1-yl)methyl)-N-(1-(2-chloro-6-fluo… | homo-4-mer | 99.63 | 4×9WH; 4×NAD; | |||
| Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and str… | homo-4-mer | 100 | 4×NAD; 6×TCL; | |||
| Crystal structure of M. tuberculosis InhA inhibited by PT504 | homo-4-mer | 100 | 4×NAD; 4×XTW; | |||
| Crystal structure of M. tuberculosis InhA inhibited by PT511 | homo-4-mer | 100 | 4×NAD; 4×XT3; | |||
| Crystal structure of Mycobacterium tuberculosis enoyl reductase (InhA) inhibited by 5-octyl-2-pheno… | homo-4-mer | 100.0 | 4×NAD; | |||
| Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and str… | homo-4-mer | 100 | 4×NAD; 4×GEQ; | |||
| LONG FATTY ACID CHAIN ENOYL-ACP REDUCTASE (INHA) IN COMPLEX WITH AN ISONICOTINIC-ACYL-NADH INHIBITOR | homo-4-mer | 99.63 | 4×ZID; | |||
| Mtb InhA complex with Pyradizinone compound 1 | homo-4-mer | 99.62 | 4×NAD; 4×41I; | |||
| Crystal structure of M. tuberculosis InhA inhibited by PT501 | homo-4-mer | 100 | 4×NAD; 5×XT5; 6×CL; 1×NA; | |||
| Crystal structure of InhA bound to triclosan derivative | homo-4-mer | 100 | 4×NAD; 4×JPJ; | |||
| M.TB. ENOYL-ACP REDUCTASE (INHA) IN COMPLEX WITH NAD+ AND C16-FATTY-ACYL-SUBSTRATE | homo-4-mer | 100 | 4×NAD; 2×THT; | |||
| Crystal structure of Mycobacterium tuberculosis enoyl reductase (InhA) inhibited by 5-pentyl-2-phen… | homo-4-mer | 100 | 4×5PP; 4×NAD; | |||
| InhA (T2A mutant) complexed with N-(1-(pyrimidin-2-yl)piperidin-4-yl)acetamide | homo-4-mer | 99.63 | 4×NAD; 3×9W2; | |||
| Structure of the M.tuberculosis enoyl-reductase InhA in complex with GSK625 | homo-4-mer | 100 | 4×NAD; 4×6KA; | |||
| InhA (T2A mutant) complexed with 1-(Pyridin-3-ylmethyl)-3-(1-(pyrimidin-2-yl)piperidin-4-yl)urea | homo-4-mer | 100 | 4×NAD; 4×9WE; 4×PO4; | |||
| Crystal structure of M. tuberculosis InhA in complex with NAD+ and 2-pyrazol-1-ylbenzoic acid | homo-4-mer | 100 | 4×NAD; 4×LT8; | |||
| Crystal structure of InhA in complex with AP-124 inhibitor | homo-4-mer | 100 | 2×JVZ; 4×NAD; | |||
| Crystal structure of M. tuberculosis InhA in complex with NAD+ and 2-(4-chloro-3-nitrobenzoyl)benzo… | homo-4-mer | 100 | 4×NAD; 4×9FN; | |||
| Crystal structure of M. tuberculosis InhA in complex with NAD+ and 3-(3-chlorophenyl)propanoic acid | homo-4-mer | 100 | 4×NAD; 4×LSQ; 4×EPE; | |||
| Structure of the apo form of InhA from Mycobacterium tuberculosis | homo-4-mer | 100.0 | 2×MES; | |||
| Crystal structure of M. tuberculosis InhA in complex with NAD+ and 3-[3-(trifluoromethyl)phenyl]pro… | homo-4-mer | 100 | 4×NAD; 4×LRW; | |||
| Multiple binding modes of inhibitor PT155 to the Mycobacterium tuberculosis enoyl-ACP reductase Inh… | homo-4-mer | 100 | 4×NAD; 4×1S5; 2×2NV; | |||
| InhA (T2A mutant) complexed with (4-((1H-pyrazol-1-yl)methyl)phenyl)methanol | homo-4-mer | 100 | 4×NAD; 4×9VQ; 12×ETX; | |||
| Mycobacterium tuberculosis InhA-S94A mutant in complex with NADH | homo-4-mer | 99.62 | 4×NAI; | |||
| Crystal structure of Mycobacterium tuberculosis enoyl reductase complexed with N-(5-chloro-2-methyl… | homo-4-mer | 100 | 4×NAD; 4×744; | |||
| Mycobacterium tuberculosis InhA (S94A) bound with INH-NAD adduct | homo-4-mer | 99.62 | 4×ZID; | |||
| InhA (T2A mutant) complexed with ethyl 2-methyl-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate | homo-4-mer | 100 | 4×9VZ; 4×NAD; 12×ETX; | |||
| Crystal structure of wild-type of Enoyl-ACP(CoA) reductase from Mycobacterium tuberculosis in compl… | homo-4-mer | 100 | 4×NAI; 4×LYS; | |||
| InhA (T2A mutant) complexed with 2,6-Dimethyl-3-(1-(pyrimidin-2-yl)piperidin-4-yl)pyridin-4(1H)-one | homo-4-mer | 100 | 4×NAD; 4×9W8; 16×ETX; 4×SO4; | |||
| Crystal structure of InhA_T266E:NADH complex | homo-4-mer | 99.62 | 4×NAD; 4×MPD; | |||
| Crystal structure of InhA_T266D:NADH complex | homo-4-mer | 99.62 | 4×NAD; 4×MPD; | |||
| InhA (T2A mutant) complexed with 1-benzyl-3-methyl-1H-pyrazol-5-amine | homo-4-mer | 100 | 4×NAD; 4×9W5; | |||
| Crystal structure of InhA(S94A) mutant in complex with OH-141 | homo-4-mer | 99.61 | 3×NAD; 1×I4I; | |||
| structure of InhA from Mycobacterium tuberculosis in complex with 5-(((4-(2-hydroxyphenoxy)benzyl)(… | homo-4-mer | 100.0 | 4×NAD; | |||
| Crystal structure of wild-type InhA:NADH complex | homo-4-mer | 100 | 4×NAD; 4×MPD; | |||
| InhA (T2A mutant) complexed with 4-((5-Amino-3-methyl-1H-pyrazol-1-yl)methyl)-N-(2-chloro-4-fluorob… | homo-4-mer | 100 | 4×9WK; 4×NAD; | |||
| Crystal structure of InhA(S94A) mutant in complex with pyridomycin | homo-4-mer | 99.61 | 4×PYW; | |||
| Crystal structure of M. tuberculosis InhA in complex with NAD+ and N-(3-(aminomethyl)phenyl)-5-chlo… | homo-4-mer | 100 | 4×NAD; 4×LTK; | |||
| The effect of isoleucine to alanine mutation on InhA enzyme crystallization pattern and substrate b… | homo-4-mer | 99.62 | 4×NAD; 4×TCU; 4×ETE; 4×EPE; | |||
| Mycobacterium tuberculosis InhA in complex with NADH | homo-4-mer | 100 | 4×NAI; | |||
| Mycobacterium tuberculosis InhA-D148G mutant in complex with NADH | homo-4-mer | 99.62 | 4×NAI; | |||
| Structure of Mycobacterium tuberculosis enoyl-ACP reductase with bound INH-NADP. | homo-4-mer | 100 | 4×DG1; | |||
| Mycobacterium tuberculosis InhA bound with PTH-NAD adduct | homo-4-mer | 100 | 4×P1H; | |||
| Crystal structure of InhA in complex with 3-nitropropanoic acid inhibitor | homo-4-mer | 100 | 4×NAD; 4×3NP; 1×GOL; | |||
| InhA (T2A mutant) complexed with 2,6-dimethyl-3-phenylpyridin-4(1H)-one | homo-4-mer | 100.0 | 4×9WB; 4×NAD; | |||
| InhA (T2A mutant) complexed with 5-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)-N-ethyl-1,3,4-thiadiazol-… | homo-4-mer | 100.0 | 4×9VT; 4×NAD; | |||
| InhA (T2A mutant) complexed with 1-cyclohexyl-3-(pyridin-3-ylmethyl)urea | homo-4-mer | 100 | 4×NAD; 4×9VW; 4×ETX; | |||
| Mycobacterium tuberculosis InhA bound to NITD-564 | homo-4-mer | 100 | 4×NAD; 4×3KX; | |||
| Compensation of the effect of isoleucine to alanine mutation by designed inhibition in the InhA enz… | homo-4-mer | 99.62 | 4×NAD; 4×53K; | |||
| CRYSTAL STRUCTURE AND FUNCTION OF THE ISONIAZID TARGET OF MYCOBACTERIUM TUBERCULOSIS | homo-2-mer | 99.63 | 2×NAD; | |||
| CRYSTAL STRUCTURE AND FUNCTION OF THE ISONIAZID TARGET OF MYCOBACTERIUM TUBERCULOSIS | homo-2-mer | 99.25 | 2×NAD; | |||
| Enoyl acyl carrier protein reductase InhA in complex with N-(4-methylbenzoyl)-4-benzylpiperidine | monomer | 100 | 1×NAD; 1×4PI; | |||
| CRYSTAL STRUCTURE OF THE INHA FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH AN12855, EBSI 4333. | monomer | 100 | 1×9JM; | |||
| CRYSTAL STRUCTURE OF THE INHA FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH AN12855, EBSI 4333. | monomer | 100.0 | 1×9JA; | |||
| CRYSTAL STRUCTURE OF THE INHA FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH AN12855, EBSI 4333. | monomer | 100.0 | 1×9JA; | |||
| Mycobacterium tuberculosis InhA bound to NITD-916 | monomer | 100 | 1×NAD; 1×3KY; | |||
| CRYSTAL STRUCTURE OF THE INHA FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH AN12855, EBSI 4333. | monomer | 100.0 | 1×9JJ; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6sq5.1.D | homo-4-mer | 0.91 | 4×NAD; 4×LRW; | 100.00 | ||